Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 2/20 | 0.47 |
| ▸ | ITGB6 | P18564 | 2/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 6/20 | 0.42 |
| ▸ | PPARA | Q07869 | 6/20 | 0.41 |
| ▸ | PPARG | P37231 | 5/20 | 0.41 |
| ▸ | CTSS | P25774 | 2/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2864714 | 1.00 | ITGAV (0.47) | ITGAVITGB6ITGB3ITGA2BALDH1A1 | |
| SCHEMBL6543211 | 0.86 | ITGAV (0.44) | ITGAVITGB6ITGB3ITGA2BALDH1A1 | |
| SCHEMBL6543218 | 0.86 | ITGAV (0.44) | ITGAVITGB6ITGB3ITGA2BALDH1A1 | |
| SCHEMBL27589044 | 0.86 | ITGB3 (0.48) | ITGAVITGB3ITGA2BCTSKPPARA | |
| SCHEMBL2985149 | 0.86 | ITGB3 (0.48) | ITGAVITGB3ITGA2BCTSKPPARA | |
| SCHEMBL2867690 | 0.83 | PPARA (0.51) | ITGAVITGB6ITGB3ITGA2BALDH1A1 | |
| SCHEMBL2867696 | 0.83 | PPARA (0.51) | ITGAVITGB6ITGB3ITGA2BALDH1A1 | |
| SCHEMBL6544522 | 0.82 | ITGAV (0.46) | ITGAVITGB6ITGB3ITGA2BALDH1A1 | |
| SCHEMBL6544530 | 0.82 | ITGAV (0.46) | ITGAVITGB6ITGB3ITGA2BALDH1A1 | |
| SCHEMBL2870996 | 0.81 | ATM (0.39) | CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7750162-B2 | Process for preparation of nonnatural amino acid and intermediate thereof | DAISO CO., LTD. (JP) | 2010-07-06 | — | — | US | disclosed |
| US-20070208180-A1 | Process for Preparation of Nonnatural Amino Acid and Intermediate Thereof | DAISO CO., LTD. (JP) | 2007-09-06 | — | — | US | disclosed |
| EP-1739077-A1 | PROCESS FOR PRODUCTION OF NONNATURAL AMINO ACIDS AND INTERMEDIATES THEREFOR | DAISO CO., LTD. (JP) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208180-A1 | Process for Preparation of Nonnatural Amino Acid and Intermediate Thereof | BCAT1, BCAT2, AADAT | ITGAV 4121/4885ITGB6 3099/4885ITGB3 3775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.